Levetiracetam Sandoz

Levetiracetam, the active ingredient in Levetiracetam Sandoz, is an Anticonvulsant presented as an oral tablet for oral use. It is employed to control partial‑onset, generalized tonic‑clonic and myoclonic seizures in individuals diagnosed with epilepsy.

GNH USA supplies Levetiracetam Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution to meet the needs of healthcare providers.

Levetiracetam is an antiepileptic drug that reduces seizure activity across several seizure types.

- Partial‑onset seizures: helps achieve seizure control in patients with focal onset epilepsy. - Generalized tonic‑clonic seizures: reduces frequency and severity of convulsive episodes. - Myoclonic seizures: diminishes rapid muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Fatigue - Somnolence - Headache - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis, angioedema) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior - Blood dyscrasias such as neutropenia or thrombocytopenia

When prescribing Levetiracetam, clinicians should consider several safety factors.

- Renal impairment: adjust dose based on creatinine clearance. - Psychiatric history: monitor for mood changes, irritability, or depression. - Pregnancy: risk unknown; use only if benefit outweighs potential fetal risk. - Concomitant CNS depressants: use caution as additive sedation may occur. - Blood counts: periodic monitoring recommended for hematologic abnormalities. - Store at ambient temperature: keep in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine, Phenytoin, Phenobarbital: strong enzyme inducers that markedly lower levetiracetam plasma levels. - Ritonavir or other potent CYP3A4 inhibitors: may increase levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol or other sedatives: may enhance central nervous system depression. - Oral contraceptives: levetiracetam may reduce hormonal efficacy, consider alternative contraception. - Antidepressants (e.g., SSRIs): monitor for increased behavioral changes.